Metabolomics Services Market Analysis And Forecast To 2032: By Product and Service (Chromatography, Metabolomics Bioinformatics Services and Mass Spectrometry, Others), By Application (Biomedical and Pharmaceutical, Agriculture and Food, Others) And Regio

The global Metabolomics Services market was valued at USD 6.3 Billion in 2022 and it is anticipated to grow up to USD 19.1 Billion by 2032, at a CAGR of 11.8% during the forecast period.

Metabolomics is an objective lens to view the complex nature of how physiology is linked to external events and conditions, as well as measure its response to perturbations such as those associated with disease. A wide range of metabolic services from discovery to targeted analysis. Metabolome means the complete set of small-molecule chemicals found within a biological sample and metabolomics refers to the systematic identification and quantification of the metabolome of a biological system at a specific point in time. The goal of metabolomics is to detect and quantify small molecules in biological fluids and tissues (metabolites). Metabolites represent a diverse group of chemical compounds such as amino acids, lipids, organic acids and environmental chemicals.

Market Trends and Drivers

Various factors leading to the growth of the metabolomics industry include the rise in funding for technological research from government as well as private organizations, along with increase in collaborations & partnerships of key players for enhancement of their product portfolio. There has been significant rise in the R&D expenditure by the key players for development of technologically advanced metabolomics platforms, which is expected to drive the growth of the market during the forecast period. The advent of personalized medication also acts as a driving force to the growth of the market.

Market Restraints and Challenges

Factors such as, data reprocessing and validation, and also the high prices of the tools and equipment are hindering the growth of the market. The market is also facing challenges like skilled labour to understand and resolve the complexity within biological samples. Moreover, the metabolomics techniques generate a large volume of heterogeneous data, which is complex and challenging to evaluate. Because of the chemical diversity of small molecule metabolites, it is not possible to study the data using a single analytical technique. All these factors are obstructing the prosperity of the overall market.

The report analyses the global Metabolomics Services market based on service, application, and region
Global Metabolomics Services Market by Services
Based on services, the market is segmented as Chromatography, Metabolomics Bioinformatics Services, Mass Spectrometry, and Others. Based on Product and Service, the metabolomics instruments segment dominates the overall market with a share of almost 60 percent in 2020, which is due to the rapid adoption of metabolomics and smooth technological operations that further leads to workflow efficiency, precision, reliability, and processing data.
Global Metabolomics Services Market by Application
Based on application, the market is segmented as Biomedical and Pharmaceutical, Agriculture, Food, and Others. The Biomedical and Pharmaceutical segment held substantial market share in 2021 and is anticipated to witness notable growth to reach highest market share and CAGR by 2032. This is due to the increased adoption of metabolic biomarkers and technological advancements. Also, among all chronic diseases, the increasing cases of cancers globally are a significant driver for drug discovery and biomarkers. As per the American Cancer Society, Global Cancer Facts statistics estimated that by 2040, the overall number of cases is expected to grow upto 27.5 million new cancer cases and 16.3 million cancer deaths. As the number of cases are rising, more and more people are going for rapid oncology tests, the demand for new drug discovery is growing at a rapid pace.

Geographical Analysis of Global Metabolomics Services Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. In 2022, The Americas regional market is expected to hold the market's principal share. This is due to the swelling patient population base that is suffering from cancer, and cardiovascular diseases are predicted to boost the Metabolomics Services Market growth in this region. The European market holds the next major position in the metabolomics services market. Numerous companies in the region provide metabolomics services, which is predicted to drive the region's growth in the metabolomics services market. The Asia Pacific regional metabolomics market is estimated to be the fastest mounting region due to many patient populations suffering from chronic disease and collective demand for therapy. .

Major Players in the Global Metabolomics Services Market

The key players in the market Agilent Technologies, Inc. (US), Waters (US), Bruker (US), TMIC (CANADA), Thermo Fisher Scientific (US), Biocrates Life Sciences AG (AUSTRIA), Creative Proteomics (US), Human Metabolome Technologies America Inc (JAPAN), Shimazdu Corporation (Japan), and Metabolon, INC (US). among others, among others.

COVID-19 Impact:

The industry soared to the challenge posed by COVID, working by employing unique ways to bolster the metabolomics services market share. The metabolome is exceptionally dynamic, and metabolism shifts often lead to clinical phenotype changes. The use of metabolomics is being leveraged to shape our understanding of COVID-19, which could play a vital role. The fruitful cases for biomarker study in pneumonia, sepsis, and comorbidities related to many COVID-19 infections indicate the possibility of metabolomics to bring about an adapted health care strategy for Covid-19, delivering safe and effective treatments to patients.

Recent Developments:In July 2021, Thermo Fisher Scientific along with the University of California launched a research collaboration, to provide innovations, standard operating procedures, and best practices to the metabolomics community. These initiatives are sure to provide robust market growth opportunities in the future.In June 2021, Thermo Fischer Scientific launched the Next-Generation of MS-Based Solutions Orbitrap IQ-X Tribrid mass spectrometer, which was specially designed to reveal complex chemical structures for compound identification. It also involves the process of structure elucidation of small molecules combining industry-leading mass analyzer technology with intelligent automation, real-time decision making, intuitive software, etc.In April 2021, BioMerieux received CE Marking for the VITEK MS PRIME, a novel MALDI-TOF mass spectrometry identification system, which is a crucial step in the microbiology workflow.In September, 2020, Waters Corporation announced the establishment of Immerse Cambridge, a research laboratory in the heart of Cambridge’s Kendall Square, where Waters partnered with academia to accelerate the next generation of scientific advancementsIn January 2020, Agilent and Thermo Fisher extended their collaboration to enhance the compatibility of Thermo Fisher’s analytical systems with Agilent’s OpenLAb Chromatography Data System, which allows users to streamline quality control workflows through improved compatibility and high-performance liquid chromatography instrumentation.Frequently Asked Questions

Q1. How big is the Metabolomics Services Market?Ans. The global Metabolomics Services market was valued at USD 6.3 Billion in 2022 and it is anticipated to grow up to USD 19.1 Billion by 2032, at a CAGR of 11.8% during the forecast period.Q2. What is the Metabolomics Services Market growth rate?Ans. The growth rate of the Metabolomics Services Market is 11.8%Q3. Which region holds a major market share for the market?Ans. North America holds a major market share of the Metabolomics Services Market in 2021.Q4. Which segment accounted for the largest Metabolomics Services Market share?Ans. By application, the Biomedical and Pharmaceutical segment accounted for the largest Metabolomics Services Market share.Q5. Who are the key players in the Metabolomics Services Market?Ans. The global Metabolomics Services Market report includes players such as Agilent Technologies, Inc. (US), Waters (US), Bruker (US), TMIC (CANADA), Thermo Fisher Scientific (US), Biocrates Life Sciences AG (AUSTRIA), Creative Proteomics (US), Human Metabolome Technologies America Inc (JAPAN), Shimazdu Corporation (Japan), and Metabolon, INC (US). among others.Q6. What are the factors driving the Metabolomics Services Market growth?Ans. The surge in cancer cases globally in different body areas is predicted to motivate the metabolomics services.Q7. What are the key growth strategies of Metabolomics Services Market players?Ans. The key growth strategies of Metabolomics Services Market players are product launch and product approval.Q8. Which region will provide more business opportunities for the Metabolomics Services Market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the Metabolomics Services Market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.